Basic Information
RNALocate ID: | RLID:11001322 |
RNA Symbol: | hsa-miR-148a-3p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-148a-3p |
RNA ID: | miRBase:MIMAT0000243 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 25184951 |
Tissue/Cell Line: | Human esophageal cancer cell line (EC9706) |
Method: | Next-generation RNA sequencing |
Description: | All known miRNAs in exosomes were detected at lower levels compared with their corresponding cells, whereas several novel miRNAs in exosomes were detected at higher levels compared with their corresponding cells. Data are collected from Table 3. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01001570 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:11001317 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
RLID:11001318 | Exosome | Breast milk | 22211110 |
RLID:11001319 | Exosome | Brain tissue | 23382797 |
RLID:11001320 | Exosome | Plasma | 23663360 |
RLID:11001321 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11001323 | Exosome | Saliva | 25376581 |
RLID:11001324 | Extracellular vesicle | HEK-293T cells | 22849433 |
RLID:11001325 | Microvesicle | Seminal plasma | 23539611 |
RLID:11001326 | Microvesicle | Hepatoma cells | 23771658 |
RLID-D:11000041 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Kidney tissue|Lymphoma tissue|Mast cells|Seminal fluid|Tongue tissue | |
RLID-D:11000310 | Microvesicle | Blood|Breast cell line|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-148a-3p | Splenic marginal zone lymphoma | MNDR-E-MI-15916 |
MNDR | hsa-miR-148a-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-15917 |
MNDR | hsa-miR-148a-3p | Oral squamous cell carcinoma | MNDR-E-MI-15918 |
MNDR | hsa-miR-148a-3p | Medulloblastoma | MNDR-E-MI-15919 |
MNDR | hsa-miR-148a-3p | Lymphoma | MNDR-E-MI-15920 |
MNDR | hsa-miR-148a-3p | Lymphoma non-hodgkin | MNDR-E-MI-15921 |
MNDR | hsa-miR-148a-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-15922 |
MNDR | hsa-miR-148a-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-15923 |
MNDR | hsa-miR-148a-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-15924 |
MNDR | hsa-miR-148a-3p | Breast cancer luminal | MNDR-E-MI-15925 |
MNDR | hsa-miR-148a-3p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-15926 |
MNDR | hsa-miR-148a-3p | Autosomal recessive limb-girdle muscular dystrophy type 2a | MNDR-E-MI-15927 |
MNDR | hsa-miR-148a-3p | Dermatomyositis | MNDR-E-MI-15928 |
MNDR | hsa-miR-148a-3p | Castration-resistant prostate cancer | MNDR-E-MI-15929 |
MNDR | hsa-miR-148a-3p | Gastric cancer | MNDR-E-MI-15930 |
MNDR | hsa-miR-148a-3p | Alzheimer disease | MNDR-E-MI-15931 |
MNDR | hsa-miR-148a-3p | Intracranial aneurysm | MNDR-E-MI-15932 |
MNDR | hsa-miR-148a-3p | Bladder cancer | MNDR-E-MI-15933 |
MNDR | hsa-miR-148a-3p | Esophageal carcinoma | MNDR-E-MI-15934 |
MNDR | hsa-miR-148a-3p | Dysautonomia familial | MNDR-E-MI-15935 |
MNDR | hsa-miR-148a-3p | Myotonic dystrophy | MNDR-E-MI-15936 |
MNDR | hsa-miR-148a-3p | Muscular dystrophy duchenne | MNDR-E-MI-15937 |
MNDR | hsa-miR-148a-3p | Leukemia | MNDR-E-MI-15938 |
MNDR | hsa-miR-148a-3p | Huntington disease | MNDR-E-MI-15939 |
MNDR | hsa-miR-148a-3p | Chorea | MNDR-E-MI-15940 |
MNDR | hsa-miR-148a-3p | Cardiovascular disease | MNDR-E-MI-15941 |
MNDR | hsa-miR-148a-3p | Parkinson disease | MNDR-E-MI-15942 |
MNDR | hsa-miR-148a-3p | Breast cancer | MNDR-E-MI-15943 |
MNDR | hsa-miR-148a-3p | Neuroendocrine neoplasia | MNDR-E-MI-15944 |
MNDR | hsa-miR-148a-3p | Pituitary neoplasms | MNDR-E-MI-15945 |
MNDR | hsa-miR-148a-3p | Pancreatic cancer | MNDR-E-MI-15946 |
MNDR | hsa-miR-148a-3p | Intrahepatic cholestasis | MNDR-E-MI-15947 |
MNDR | hsa-miR-148a-3p | Melanoma | MNDR-E-MI-15948 |
MNDR | hsa-miR-148a-3p | Rectum adenocarcinoma | MNDR-E-MI-15949 |
MNDR | hsa-miR-148a-3p | Nephroblastoma | MNDR-E-MI-15950 |
MNDR | hsa-miR-148a-3p | Colon cancer | MNDR-E-MI-15951 |
MNDR | hsa-miR-148a-3p | Ischemic attack transient | MNDR-E-MI-15952 |
MNDR | hsa-miR-148a-3p | Colon adenocarcinoma | MNDR-E-MI-15953 |
MNDR | hsa-miR-148a-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-15954 |
MNDR | hsa-miR-148a-3p | Familial ovarian cancer | MNDR-E-MI-15955 |
MNDR | hsa-miR-148a-3p | Prostate adenocarcinoma | MNDR-E-MI-15956 |
MNDR | hsa-miR-148a-3p | Hematologic cancer | MNDR-E-MI-15957 |
MNDR | hsa-miR-148a-3p | Carcinoma ductal breast | MNDR-E-MI-15958 |
MNDR | hsa-miR-148a-3p | Glioblastoma | MNDR-E-MI-15959 |
MNDR | hsa-miR-148a-3p | Glioma | MNDR-E-MI-15960 |
MNDR | hsa-miR-148a-3p | Nemaline myopathy | MNDR-E-MI-15961 |
MNDR | hsa-miR-148a-3p | Central nervous system lymphoma | MNDR-E-MI-15962 |
MNDR | hsa-miR-148a-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-15963 |
MNDR | hsa-miR-148a-3p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-15964 |
MNDR | hsa-miR-148a-3p | Uterine cancer | MNDR-E-MI-15965 |
MNDR | hsa-miR-148a-3p | Cervical squamous cell carcinoma | MNDR-E-MI-15966 |
MNDR | hsa-miR-148a-3p | Pituitary adenoma | MNDR-E-MI-15967 |
MNDR | hsa-miR-148a-3p | Lung squamous cell carcinoma | MNDR-E-MI-15968 |
MNDR | hsa-miR-148a-3p | Lung adenocarcinoma | MNDR-E-MI-15969 |
MNDR | hsa-miR-148a-3p | Acute myocarditis | MNDR-E-MI-15970 |
MNDR | hsa-miR-148a-3p | Thyroid carcinoma | MNDR-E-MI-15971 |
MNDR | hsa-miR-148a-3p | Bladder urothelial carcinoma | MNDR-E-MI-15972 |
MNDR | hsa-miR-148a-3p | Pancreatic adenocarcinoma | MNDR-E-MI-15973 |
MNDR | hsa-miR-148a-3p | Skin cancer | MNDR-E-MI-15974 |
MNDR | hsa-miR-148a-3p | Kidney renal clear cell carcinoma | MNDR-E-MI-15975 |
MNDR | hsa-miR-148a-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-15976 |
MNDR | hsa-miR-148a-3p | Renal clear cell carcinoma | MNDR-E-MI-15977 |
MNDR | hsa-miR-148a-3p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-15978 |
MNDR | hsa-miR-148a-3p | Cholangiocarcinoma | MNDR-E-MI-15979 |
MNDR | hsa-miR-148a-3p | Esophageal cancer | MNDR-E-MI-15980 |
MNDR | hsa-miR-148a-3p | Liver cirrhosis | MNDR-E-MI-15981 |
MNDR | hsa-miR-148a-3p | Lung small cell carcinoma | MNDR-E-MI-15982 |
MNDR | hsa-miR-148a-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-15983 |
MNDR | hsa-miR-148a-3p | Aortic valve disease | MNDR-E-MI-15984 |
MNDR | hsa-miR-148a-3p | Breast invasive carcinoma | MNDR-E-MI-15985 |
MNDR | hsa-miR-148a-3p | Early hepatocellular carcinoma | MNDR-E-MI-15986 |
MNDR | hsa-miR-148a-3p | Familiar ovarian carcinoma | MNDR-E-MI-15987 |
MNDR | hsa-miR-148a-3p | B-cell lymphoma | MNDR-E-MI-15988 |
MNDR | hsa-miR-148a-3p | Rheumatoid arthritis | MNDR-E-MI-15989 |
MNDR | hsa-miR-148a-3p | T-cell leukemia | MNDR-E-MI-15990 |
MNDR | hsa-miR-148a-3p | Malignant pleural mesothelioma | MNDR-E-MI-15991 |
MNDR | hsa-miR-148a-3p | Hodgkin lymphoma | MNDR-E-MI-15992 |
MNDR | hsa-miR-148a-3p | Burkitt lymphoma | MNDR-E-MI-15993 |
MNDR | hsa-miR-148a-3p | Neuromyelitis optica | MNDR-E-MI-15994 |
MNDR | hsa-miR-148a-3p | Skin cutaneous melanoma | MNDR-E-MI-15995 |
MNDR | hsa-miR-148a-3p | Skin melanoma | MNDR-E-MI-15996 |
MNDR | hsa-miR-148a-3p | Acute myelocytic leukemia | MNDR-E-MI-15997 |
MNDR | hsa-miR-148a-3p | Colorectal cancer | MNDR-E-MI-15998 |
MNDR | hsa-miR-148a-3p | Multiple myeloma | MNDR-E-MI-15999 |
MNDR | hsa-miR-148a-3p | Acute lymphocytic leukemia | MNDR-E-MI-16000 |
MNDR | hsa-miR-148a-3p | Ependymoma | MNDR-E-MI-16001 |
MNDR | hsa-miR-148a-3p | Nasopharyngeal cancer | MNDR-E-MI-16002 |
MNDR | hsa-miR-148a-3p | Epstein-barr virus infections | MNDR-E-MI-16003 |
MNDR | hsa-miR-148a-3p | Stroke lacunar | MNDR-E-MI-16004 |
MNDR | hsa-miR-148a-3p | Low grade dysplastic nodule | MNDR-E-MI-16005 |
MNDR | hsa-miR-148a-3p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-16006 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ACVR1 | Homo sapiens | RR00038737 |
TOP